Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00825500Phase 2Completed
A Phase 2 trial of loxapine in migraine, sponsored by Alexza Pharmaceuticals Inc. Started Jan 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00825500.